Literature DB >> 30944420

Identification of a 1p21 independent functional variant for abdominal obesity.

Lu Liu1,2, Yu-Fang Pei2,3, Tao-Le Liu4, Hong-Wen Deng5,6, Lei Zhang7,8, Wen-Zhu Hu1,2, Xiao-Lin Yang1,2, Shan-Cheng Li9, Rong Hai10, Shu Ran11, Lan Juan Zhao12, Hui Shen12, Qing Tian12, Hong-Mei Xiao13, Kun Zhang14.   

Abstract

OBJECTIVES: Aiming to uncover the genetic basis of abdominal obesity, we performed a genome-wide association study (GWAS) meta-analysis of trunk fat mass adjusted by trunk lean mass (TFMadj) and followed by a series of functional investigations.
SUBJECTS: A total of 11,569 subjects from six samples were included into the GWAS meta-analysis.
METHODS: Meta-analysis was performed by a weighted fixed-effects model. In silico replication analysis was performed in the UK-Biobank (UKB) sample (N = 331,093) and in the GIANT study (N up to 110,204). Cis-expression QTL (cis-eQTL) analysis, dual-luciferase reporter assay and electrophoresis mobility shift assay (EMSA) were conducted to examine the functional relevance of the identified SNPs. At last, differential gene expression analysis (DGEA) was performed.
RESULTS: We identified an independent SNP rs12409479 at 1p21 (MAF = 0.07, p = 7.26 × 10-10), whose association was replicated by the analysis of TFM in the UKB sample (one-sided p = 3.39 × 10-3), and was cross-validated by the analyses of BMI (one-sided p = 0.03) and WHRadj (one-sided p = 0.04) in the GIANT study. Cis-eQTL analysis demonstrated that allele A at rs12409479 was positively associated with PTBP2 expression level in subcutaneous adipose tissue (N = 385, p = 4.15 × 10-3). Dual-luciferase reporter assay showed that the region repressed PTBP2 gene expression by downregulating PTBP2 promoter activity (p < 0.001), and allele A at rs12409479 induced higher luciferase activity than allele G did (p = 4.15 × 10-3). EMSA experiment implied that allele A was more capable of binding to unknown transcription factors than allele G. Lastly, DGEA showed that the level of PTBP2 expression was higher in individuals with obesity than in individuals without obesity (N = 20 and 11, p = 0.04 and 9.22 × 10-3), suggesting a regulatory role in obesity development.
CONCLUSIONS: Taken together, we hypothesize a regulating path from rs12409479 to trunk fat mass development through its allelic specific regulation of PTBP2 gene expression, thus providing some novel insight into the genetic basis of abdominal obesity.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30944420      PMCID: PMC6776704          DOI: 10.1038/s41366-019-0350-z

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  49 in total

1.  Twins and virtual twins: bases of relative body weight revisited.

Authors:  N L Segal; D B Allison
Journal:  Int J Obes Relat Metab Disord       Date:  2002-04

Review 2.  Obesity.

Authors:  David W Haslam; W Philip T James
Journal:  Lancet       Date:  2005-10-01       Impact factor: 79.321

Review 3.  The search for human obesity genes.

Authors:  A G Comuzzie; D B Allison
Journal:  Science       Date:  1998-05-29       Impact factor: 47.728

Review 4.  Genetics of human hypertension.

Authors:  Anupam Agarwal; Gordon H Williams; Naomi D L Fisher
Journal:  Trends Endocrinol Metab       Date:  2005-04       Impact factor: 12.015

Review 5.  Genetics of obesity and the prediction of risk for health.

Authors:  Andrew J Walley; Alexandra I F Blakemore; Philippe Froguel
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

Review 6.  Genetic and environmental factors in relative body weight and human adiposity.

Authors:  H H Maes; M C Neale; L J Eaves
Journal:  Behav Genet       Date:  1997-07       Impact factor: 2.805

7.  The economic impact of obesity in the United States.

Authors:  Ross A Hammond; Ruth Levine
Journal:  Diabetes Metab Syndr Obes       Date:  2010-08-30       Impact factor: 3.168

Review 8.  Genome-wide association studies of obesity and metabolic syndrome.

Authors:  Tove Fall; Erik Ingelsson
Journal:  Mol Cell Endocrinol       Date:  2012-09-03       Impact factor: 4.102

9.  Why is the developed world obese?

Authors:  Sara Bleich; David Cutler; Christopher Murray; Alyce Adams
Journal:  Annu Rev Public Health       Date:  2008       Impact factor: 21.981

10.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors:  Marie Ng; Tom Fleming; Margaret Robinson; Blake Thomson; Nicholas Graetz; Christopher Margono; Erin C Mullany; Stan Biryukov; Cristiana Abbafati; Semaw Ferede Abera; Jerry P Abraham; Niveen M E Abu-Rmeileh; Tom Achoki; Fadia S AlBuhairan; Zewdie A Alemu; Rafael Alfonso; Mohammed K Ali; Raghib Ali; Nelson Alvis Guzman; Walid Ammar; Palwasha Anwari; Amitava Banerjee; Simon Barquera; Sanjay Basu; Derrick A Bennett; Zulfiqar Bhutta; Jed Blore; Norberto Cabral; Ismael Campos Nonato; Jung-Chen Chang; Rajiv Chowdhury; Karen J Courville; Michael H Criqui; David K Cundiff; Kaustubh C Dabhadkar; Lalit Dandona; Adrian Davis; Anand Dayama; Samath D Dharmaratne; Eric L Ding; Adnan M Durrani; Alireza Esteghamati; Farshad Farzadfar; Derek F J Fay; Valery L Feigin; Abraham Flaxman; Mohammad H Forouzanfar; Atsushi Goto; Mark A Green; Rajeev Gupta; Nima Hafezi-Nejad; Graeme J Hankey; Heather C Harewood; Rasmus Havmoeller; Simon Hay; Lucia Hernandez; Abdullatif Husseini; Bulat T Idrisov; Nayu Ikeda; Farhad Islami; Eiman Jahangir; Simerjot K Jassal; Sun Ha Jee; Mona Jeffreys; Jost B Jonas; Edmond K Kabagambe; Shams Eldin Ali Hassan Khalifa; Andre Pascal Kengne; Yousef Saleh Khader; Young-Ho Khang; Daniel Kim; Ruth W Kimokoti; Jonas M Kinge; Yoshihiro Kokubo; Soewarta Kosen; Gene Kwan; Taavi Lai; Mall Leinsalu; Yichong Li; Xiaofeng Liang; Shiwei Liu; Giancarlo Logroscino; Paulo A Lotufo; Yuan Lu; Jixiang Ma; Nana Kwaku Mainoo; George A Mensah; Tony R Merriman; Ali H Mokdad; Joanna Moschandreas; Mohsen Naghavi; Aliya Naheed; Devina Nand; K M Venkat Narayan; Erica Leigh Nelson; Marian L Neuhouser; Muhammad Imran Nisar; Takayoshi Ohkubo; Samuel O Oti; Andrea Pedroza; Dorairaj Prabhakaran; Nobhojit Roy; Uchechukwu Sampson; Hyeyoung Seo; Sadaf G Sepanlou; Kenji Shibuya; Rahman Shiri; Ivy Shiue; Gitanjali M Singh; Jasvinder A Singh; Vegard Skirbekk; Nicolas J C Stapelberg; Lela Sturua; Bryan L Sykes; Martin Tobias; Bach X Tran; Leonardo Trasande; Hideaki Toyoshima; Steven van de Vijver; Tommi J Vasankari; J Lennert Veerman; Gustavo Velasquez-Melendez; Vasiliy Victorovich Vlassov; Stein Emil Vollset; Theo Vos; Claire Wang; XiaoRong Wang; Elisabete Weiderpass; Andrea Werdecker; Jonathan L Wright; Y Claire Yang; Hiroshi Yatsuya; Jihyun Yoon; Seok-Jun Yoon; Yong Zhao; Maigeng Zhou; Shankuan Zhu; Alan D Lopez; Christopher J L Murray; Emmanuela Gakidou
Journal:  Lancet       Date:  2014-05-29       Impact factor: 79.321

View more
  3 in total

1.  PTBP2 - a gene with relevance for both Anorexia nervosa and body weight regulation.

Authors:  Yiran Zheng; Luisa Sophie Rajcsanyi; Beate Herpertz-Dahlmann; Jochen Seitz; Martina de Zwaan; Wolfgang Herzog; Stefan Ehrlich; Stephan Zipfel; Katrin Giel; Karin Egberts; Roland Burghardt; Manuel Föcker; Saad Al-Lahham; Triinu Peters; Lars Libuda; Jochen Antel; Johannes Hebebrand; Anke Hinney
Journal:  Transl Psychiatry       Date:  2022-06-09       Impact factor: 7.989

2.  Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis.

Authors:  Jihye Kim; Joon-Yong Chung; Jae Ryoung Hwang; Yoo-Young Lee; Tae-Joong Kim; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae; Chel Hun Choi; Stephen M Hewitt
Journal:  J Clin Med       Date:  2020-04-16       Impact factor: 4.241

3.  The landscape of GWAS validation; systematic review identifying 309 validated non-coding variants across 130 human diseases.

Authors:  Ammar J Alsheikh; Sabrina Wollenhaupt; Emily A King; Jonas Reeb; Sujana Ghosh; Lindsay R Stolzenburg; Saleh Tamim; Jozef Lazar; J Wade Davis; Howard J Jacob
Journal:  BMC Med Genomics       Date:  2022-04-01       Impact factor: 3.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.